Ocular Itching Reduction Study

In all three studies, DEXTENZA resulted in lower mean ocular itching scores compared with the placebo group at all time points throughout the one-month duration of the study. In two of the three studies, a higher proportion of patients had statistically significant reductions in ocular itching on Day 8, at 3 minutes, 5 minutes and 7 minutes post-challenge in the DEXTENZA group than in the placebo group. In Study 2, DEXTENZA did not meet the primary endpoint for reduction in ocular itching on Day 8.
Reference: DEXTENZA [package insert]. Bedford, MA: Ocular Therapeutix, Inc; 2021.